INSMED Inc INSM
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $606.4M | +67% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $112.3M | +1415% | FY ending Dec 31, 2019 |
| Operating income | $-1.2B | -42% | FY ending Dec 31, 2025 |
| Net income | $-1.3B | -40% | FY ending Dec 31, 2025 |
| Earnings per share | $-6.42 | -15% | FY ending Dec 31, 2025 |
| Research & development | $771.1M | +29% | FY ending Dec 31, 2025 |
| Cash from operations | $-935.0M | -37% | FY ending Dec 31, 2025 |
| Capital spending | $32.6M | +49% | FY ending Dec 31, 2025 |
| Cash | $510.4M | -8% | FY ending Dec 31, 2025 |
| Long-term debt | $541.0M | -51% | FY ending Dec 31, 2025 |
| Shareholders' equity | $739.0M | +159% | FY ending Dec 31, 2025 |
| Shares outstanding | 214M | +19% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 72 sales ($167.1M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| David R BrennanDirector | Sold | 25,000 | $124.00 | $3.1M | Sep 9, 2026 |
| Melvin Md SharokyDirector | Sold | 5,000 | $127.53 | $638K | Aug 17, 2026 |
| Roger AdsettChief Operating Officer | Sold | 239,850 | $133.27 | $32.0M | Aug 10, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan2 fills | 27,173 | $128.61 avg | $3.5M | Aug 6, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan2 fills | 10,700 | $106.06 avg | $1.1M | Jul 23, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan3 fills | 10,699 | $117.40 avg | $1.3M | Jul 9, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan2 fills | 12,302 | $109.98 avg | $1.4M | Jul 6, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan5 fills | 21,398 | $103.32 avg | $2.2M | Jun 25, 2026 |
| Michael Alexander SmithChief Legal Officer | Soldpre-set plan | 1,806 | $95.82 | $173K | Jun 22, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan | 6,515 | $94.03 | $613K | Jun 8, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan | 1,858 | $103.78 | $193K | Jun 5, 2026 |
| William LewisChair and CEO, Director | Sold | 7,605 | $102.27 | $778K | Jun 3, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan | 2,566 | $102.27 | $262K | Jun 3, 2026 |
| Sara BonsteinChief Financial Officer | Sold | 2,404 | $102.27 | $246K | Jun 3, 2026 |
| Roger AdsettChief Operating Officer | Sold | 2,370 | $102.27 | $242K | Jun 3, 2026 |
| Michael Alexander SmithChief Legal Officer | Sold | 2,159 | $102.27 | $221K | Jun 3, 2026 |
| Michael Alexander SmithChief Legal Officer | Soldpre-set plan | 6,149 | $108.47 | $667K | May 22, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan3 fills | 25,564 | $106.33 avg | $2.7M | May 18, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan | 10,479 | $117.54 | $1.2M | May 14, 2026 |
| William LewisChair and CEO, Director | Sold | 13,283 | $116.18 | $1.5M | May 13, 2026 |
| Sara BonsteinChief Financial Officer | Sold | 8,272 | $116.18 | $961K | May 13, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan2 fills | 7,854 | $114.23 avg | $897K | May 13, 2026 |
| Roger AdsettChief Operating Officer | Sold | 5,837 | $116.18 | $678K | May 13, 2026 |
| Michael Alexander SmithChief Legal Officer | Sold | 4,109 | $116.18 | $477K | May 13, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan2 fills | 12,949 | $100.40 avg | $1.3M | May 11, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan6 fills | 10,699 | $137.34 avg | $1.5M | May 4, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan4 fills | 10,699 | $143.97 avg | $1.5M | Apr 16, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan3 fills | 10,699 | $163.22 avg | $1.7M | Apr 6, 2026 |
| Roger AdsettChief Operating Officer | Soldpre-set plan3 fills | 88,060 | $164.63 avg | $14.5M | Apr 1, 2026 |
| Michael Alexander SmithChief Legal Officer | Soldpre-set plan | 19,638 | $150.98 | $3.0M | Mar 30, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan3 fills | 10,699 | $143.52 avg | $1.5M | Mar 19, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan4 fills | 10,699 | $146.03 avg | $1.6M | Mar 5, 2026 |
| Michael Alexander SmithChief Legal Officer | Soldpre-set plan3 fills | 24,774 | $155.77 avg | $3.9M | Feb 24, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan5 fills | 10,699 | $150.97 avg | $1.6M | Feb 19, 2026 |
| William LewisChair and CEO, Director | Soldpre-set plan3 fills | 13,396 | $147.79 avg | $2.0M | Feb 9, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan | 869 | $152.44 | $132K | Feb 5, 2026 |
| William LewisChair and CEO, Director | Sold | 3,009 | $156.34 | $470K | Feb 3, 2026 |
| Martina M.D. FlammerChief Medical Officer | Soldpre-set plan | 795 | $155.77 | $124K | Feb 3, 2026 |
| Roger AdsettChief Operating Officer | Sold | 791 | $156.17 | $124K | Feb 3, 2026 |
| Sara BonsteinChief Financial Officer | Sold | 748 | $156.34 | $117K | Feb 3, 2026 |
Other insider moves (53): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Utpal KoppikarDirector | Award | 6,139 | – | – | Oct 19, 2026 |
| Paul HudsonDirector | Award | 6,139 | – | – | Oct 19, 2026 |
| Roger AdsettChief Operating Officer | Option exercise3 fills | 239,850 | $20.45 avg | $4.9M | Aug 10, 2026 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan2 fills | 27,173 | $21.20 avg | $576K | Aug 6, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,700 | $24.94 avg | $267K | Jul 23, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Jul 9, 2026 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan2 fills | 12,302 | $25.80 avg | $317K | Jul 6, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 21,398 | $24.94 avg | $534K | Jun 25, 2026 |
| Samuele ButeraSVP, GM, Global Respiratory | Award | 7,342 | – | – | Jun 23, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | May 18, 2026 |
| Carol SchaferDirector | Award | 3,305 | – | – | May 13, 2026 |
| Elizabeth M AndersonDirector | Award | 3,305 | – | – | May 13, 2026 |
| Melvin Md SharokyDirector | Award | 3,305 | – | – | May 13, 2026 |
| David R BrennanDirector | Award | 3,305 | – | – | May 13, 2026 |
| Clarissa DesjardinsDirector | Award | 3,305 | – | – | May 13, 2026 |
| Leo LeeDirector | Award | 3,305 | – | – | May 13, 2026 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan | 12,949 | $17.07 | $221K | May 11, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | May 4, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Apr 16, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Apr 6, 2026 |
| Roger AdsettChief Operating Officer | Option exercisepre-set plan | 88,060 | $14.56 | $1.3M | Apr 1, 2026 |
| Michael Alexander SmithChief Legal Officer | Option exercisepre-set plan2 fills | 19,638 | $24.78 avg | $487K | Mar 30, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Mar 19, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Mar 5, 2026 |
| Melvin Md SharokyDirector | Gift | 100 | – | – | Mar 3, 2026 |
| Melvin Md SharokyDirector | Gift | 1,072 | – | – | Feb 25, 2026 |
| Melvin Md SharokyDirector | Gift4 fills | 972 | – | – | Feb 25, 2026 |
| Michael Alexander SmithChief Legal Officer | Option exercisepre-set plan | 20,248 | $17.07 | $346K | Feb 24, 2026 |
| David R BrennanDirector | Gift | 6,000 | – | – | Feb 23, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Feb 19, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Feb 9, 2026 |
| David W J McgirrDirector | Gift | 53,400 | – | – | Feb 9, 2026 |
| David W J McgirrDirector | Gift | 53,400 | – | – | Feb 9, 2026 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan | 7,982 | $65.72 | $525K | Feb 2, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Jan 20, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Jan 12, 2026 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan | 8,570 | $26.43 | $227K | Jan 6, 2026 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan2 fills | 12,303 | $25.80 avg | $317K | Jan 5, 2026 |
| Orlov S Nicole SchaefferChief People Strategy Officer | Option exercisepre-set plan | 87,290 | $13.91 | $1.2M | Jan 2, 2026 |
| Sara BonsteinChief Financial Officer | Award2 fills | 11,643 | – | – | Jan 2, 2026 |
| William LewisChair and CEO, Director | Award | 21,172 | – | – | Jan 2, 2026 |
| Martina M.D. FlammerChief Medical Officer | Awardpre-set plan2 fills | 11,643 | – | – | Jan 2, 2026 |
| Roger AdsettChief Operating Officer | Award | 5,998 | – | – | Jan 2, 2026 |
| Michael Alexander SmithChief Legal Officer | Award | 5,293 | – | – | Jan 2, 2026 |
| Orlov S Nicole SchaefferChief People Strategy Officer | Awardpre-set plan | 5,293 | – | – | Jan 2, 2026 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Dec 18, 2025 |
| William LewisChair and CEO, Director | Option exercisepre-set plan2 fills | 10,699 | $24.94 avg | $267K | Dec 4, 2025 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan | 8,895 | $25.83 | $230K | Dec 1, 2025 |
| Orlov S Nicole SchaefferChief People Strategy Officer | Option exercise | 30,000 | $26.46 | $794K | Nov 12, 2025 |
| Martina M.D. FlammerChief Medical Officer | Option exercisepre-set plan2 fills | 31,226 | $18.17 avg | $567K | Nov 11, 2025 |
| David R BrennanDirector | Gift | 60,000 | – | – | Nov 6, 2025 |
| David R BrennanDirector | Gift | 60,000 | – | – | Nov 6, 2025 |
| Michael Alexander SmithChief Legal Officer | Option exercisepre-set plan | 27,130 | $23.75 | $644K | Nov 3, 2025 |
Trades by members of Congress
2 members reported 1 buy and 6 sales since Apr 9, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Josh Gottheimer D | Sold some | $1,001–$15K | Jun 10, 2026 | Jul 7, 2026 | Joint |
| Gilbert Ray Cisneros, Jr. D | Sold | $1,001–$15K | Oct 3, 2025 | Nov 18, 202546 days later | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Sep 22, 2025 | Oct 10, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Aug 8, 2025 | Sep 12, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Jul 7, 2025 | Aug 14, 2025 | Self |
| Josh Gottheimer D | Bought | $1,001–$15K | Jun 16, 2025 | Jul 16, 2025 | Joint |
| Josh Gottheimer D | Sold some | $1,001–$15K | Apr 9, 2025 | May 14, 2025 | Joint |
Latest SEC filings
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Oct 20, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Oct 5, 2026
- Insider plans to sell 144 · Sep 10, 2026
- Insider plans to sell 144 · Aug 17, 2026
- Insider plans to sell 144 · Aug 10, 2026
- Insider plans to sell 144 · Aug 6, 2026
- News filing: Quarterly results 8-K · Aug 6, 2026
- Quarterly report 10-Q · Aug 6, 2026
- Insider plans to sell 144 · Jul 23, 2026
- News filing: Public announcement (Reg FD) 8-K · Jul 16, 2026
- Insider plans to sell 144 · Jul 9, 2026
- Insider plans to sell 144 · Jul 6, 2026
- Insider plans to sell 144 · Jun 25, 2026
- Insider plans to sell 144 · Jun 22, 2026
- Insider plans to sell 144 · Jun 8, 2026
- Insider plans to sell 144 · Jun 5, 2026
- Insider plans to sell 144 · Jun 3, 2026
- Insider plans to sell 144 · Jun 3, 2026
- Insider plans to sell 144 · Jun 3, 2026
- Insider plans to sell 144 · Jun 3, 2026
- Insider plans to sell 144 · Jun 3, 2026
- Insider plans to sell 144 · May 22, 2026
- Insider plans to sell 144 · May 18, 2026
- News filing: Shareholder vote results 8-K · May 15, 2026
- Insider plans to sell 144 · May 14, 2026
About INSMED Inc
Business description
- Industry
- Pharmaceutical Preparations
- Sector
- Life Sciences
- Headquarters
- Bridgewater, NJ
- Incorporated in
- VA
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 1104506
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.